Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes

[1]  R. Gabbay,et al.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2022, Diabetologia.

[2]  Andrea L. Cherrington,et al.  Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. , 2022, The New England journal of medicine.

[3]  Addendum. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022: Diabetes Care 2022;45(Suppl. 1):S175-S184. , 2022, Diabetes care.

[4]  D. Mauricio,et al.  Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management , 2022, Cardiovascular Diabetology.

[5]  T. Pearson,et al.  Dyslipidemia , 2007, Annals of Internal Medicine.

[6]  E. Huang,et al.  11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.

[7]  E. Huang,et al.  10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.

[8]  A. Scheen,et al.  Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2–2021 , 2021, Médecine des Maladies Métaboliques.

[9]  I. Hirsch,et al.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2021, Diabetologia.

[10]  N. Ivers,et al.  Persons With Diabetes and General/Family Practitioner Perspectives Related to Therapeutic Inertia in Type 2 Diabetes Mellitus Using Qualitative Focus Groups and the Theoretical Domains Framework: Results From the MOTION Study. , 2021, Canadian journal of diabetes.

[11]  Lawrence A Leiter,et al.  Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial. , 2021, Journal of the American College of Cardiology.

[12]  L. Ismail,et al.  Association of risk factors with type 2 diabetes: A systematic review , 2021, Computational and structural biotechnology journal.

[13]  P. Haidet,et al.  Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes , 2021, BMJ Open Diabetes Research & Care.

[14]  B. Riegel,et al.  Applying the COM-B behaviour model to overcome barriers to heart failure self-care: A practical application of a conceptual framework for the development of complex interventions (ACHIEVE study). , 2020, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[15]  L. Rydén,et al.  Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management , 2020, Diabetes Care.

[16]  K. Khunti,et al.  Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment. , 2020, Kidney international.

[17]  A. Banerjee,et al.  Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study , 2020, Diabetes, obesity & metabolism.

[18]  G. De Backer,et al.  Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V , 2020, Diabetes Care.

[19]  G. Filippatos,et al.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2020, European heart journal.

[20]  C. Mathieu,et al.  2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2019, Diabetologia.

[21]  F. Cosentino,et al.  The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.

[22]  Deepak L. Bhatt,et al.  Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD). , 2019, Circulation.

[23]  P. Wilson,et al.  Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults , 2019, Journal of the American Heart Association.

[24]  M. Quiñones,et al.  Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review , 2018, Advances in Therapy.

[25]  W. Kernan,et al.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2018, Diabetologia.

[26]  O. Pedersen,et al.  Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study , 2018, Diabetologia.

[27]  C. Johnston,et al.  Advocating for Behavior Change With Education , 2018, American journal of lifestyle medicine.

[28]  Xifeng Wu,et al.  Diabetes with early kidney involvement may shorten life expectancy by 16 years. , 2017, Kidney international.

[29]  Jeremy M. Grimshaw,et al.  A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems , 2017, Implementation Science.

[30]  Björn Eliasson,et al.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes , 2017, The New England journal of medicine.

[31]  J. De Sutter,et al.  Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology , 2015, Cardiovascular Diabetology.

[32]  M. Majella,et al.  Does audit improve diabetes care in a primary care setting? A management tool to address health system gaps , 2015, Journal of natural science, biology, and medicine.

[33]  Daniel F. Freitag,et al.  Association of Cardiometabolic Multimorbidity With Mortality. , 2015, JAMA.

[34]  Varun Vaidya,et al.  Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review , 2015, Expert review of pharmacoeconomics & outcomes research.

[35]  F. Dunne,et al.  Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria. , 2015, World journal of diabetes.

[36]  John R. White.  A Brief History of the Development of Diabetes Medications , 2014, Diabetes Spectrum.

[37]  B. Gardner.  A review and analysis of the use of ‘habit’ in understanding, predicting and influencing health-related behaviour , 2014, Health psychology review.

[38]  Sherita Hill Golden,et al.  Race/Ethnic Difference in Diabetes and Diabetic Complications , 2013, Current Diabetes Reports.

[39]  E. Huang,et al.  Personalized Decision Support in Type 2 Diabetes Mellitus: Current Evidence and Future Directions , 2013, Current Diabetes Reports.

[40]  B. Kestenbaum,et al.  Kidney disease and increased mortality risk in type 2 diabetes. , 2013, Journal of the American Society of Nephrology : JASN.

[41]  U. Pagotto,et al.  Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes , 2012, Diabetes.

[42]  Lawrence A Leiter,et al.  Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada , 2012, European journal of preventive cardiology.

[43]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[44]  K. Berridge,et al.  The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders , 2010, Brain Research.

[45]  W. T. Cade,et al.  Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting , 2008, Physical Therapy.

[46]  M. Abolfotouh,et al.  An audit of diabetes care at 3 centres in Alexandria. , 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[47]  L. Rydén,et al.  Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[48]  G. Mitchell,et al.  An audit of structured diabetes care in a rural general practice , 2006, The Medical journal of Australia.

[49]  M. Engelgau,et al.  Valuing health-related quality of life in diabetes. , 2002, Diabetes care.

[50]  Andrew Hart,et al.  Principles for Best Practice in Clinical Audit. , 2002 .

[51]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[52]  M. Vallis,et al.  Equipping providers with principles, knowledge and skills to successfully integrate behaviour change counselling into practice: a primary healthcare framework. , 2018, Public health.

[53]  Lawrence A Leiter,et al.  Treatment of Hypertension. , 2018, Canadian journal of diabetes.

[54]  Catherine B. Chan,et al.  Nutrition Therapy Diabetes Canada Clinical Practice Guidelines Expert Committee , 2018 .

[55]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[56]  Un Desa.  Transforming our world : The 2030 Agenda for Sustainable Development , 2016 .

[57]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[58]  U. Pagotto,et al.  Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes Results From a Long-Term Prospective Study , 2012 .

[59]  H. Swidan,et al.  Quality improvement programme for diabetes care in family practice settings in Dubai. , 2007, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.